Digital Health Frontier Column

By John Halamka and Paul Cerrato — Chatbots are offering a quick way for patients to collect and access their records, but the tools they are using are not always secure, or accurate.

By John Halamka and Paul Cerrato — The best medicine combines high tech and high touch approaches to patient care.

By John Halamka and Paul Cerrato—The AI agent offers several labor-saving features but also poses several serious risks.

By John Halamka and Paul Cerrato—Genomics, transcriptomics, proteomics, and metabolomics are increasingly helping to uncover the molecular mechanisms underlying many diseases.

By John Halamka and Paul Cerrato—Pancreatic cancer remains one of the most life-threatening malignancies because it is so difficult to detect in its earliest, most manageable stage. Recent developments in AI, however, suggest it may be possible to improve the diagnostic process.  

By John Halamka and Paul Cerrato—An innovative approach that incorporates a massive, de-identified data set of EHR records is transforming the research landscape.

By John Halamka and Paul Cerrato—Many doctors worry that AI algorithms are pushing them to the sidelines. But others see these digital tools as partners in the quest to provide the best possible patient care.

By John Halamka and Paul Cerrato—None of us are born with the ability to systematically weigh evidence or evaluate complex arguments, but learning these skills will have a profound impact on our personal and professional lives.

By John Halamka and Paul Cerrato—Several AI algorithms are now available to improve patient care in Type 1 and Type 2 diabetes. Some of these digital tools may even personalize treatment using multimodal data.

By John Halamka and Paul Cerrato — The capabilities of generative AI continue to grow.  Using them wisely will likely improve clinical decision making.